Elucidation of the roles of Pim-1 induced under hypoxia in pancreatic cancer and its application to the cancer therapy
Elucidation of the roles of Pim-1 induced under hypoxia in pancreatic cancer and its application to the cancer therapy
批准号:
16390202
负责人:
KOBAYASHI Masanobu
金额:
$9.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
在本研究中,我们基于Pim-1蛋白在缺氧条件下表达增强的发现,研究抑制Pim-1活性是否能有效治疗胰腺癌。根据已有报道表明,由11个精氨酸组成的多肽融合蛋白可以通过细胞质膜,我们构建了一个编码血小板生成素显性阴性Pim-1蛋白11个精氨酸信号序列的表达载体。PCI-43。细胞,一种胰腺癌细胞系,皮下接种到SCID小鼠的背部。然后在小鼠股肌内注射载体。注射PIM-1显性阴性表达载体21天后,各组小鼠肿瘤消失,空表达载体组肿瘤生长。这些结果提示,利用Pim-1显性阴性表达载体进行基因治疗可能对肿瘤有效。然而,在临床试验中,应减少注射表达载体的剂量。我们寻找能抑制Pim-1功能的小化合物库。我们发现了14个小的化合物,它们抑制PIM-1的磷酸化活性超过40%。我们现在正计划研究这些化合物的体内抗肿瘤作用。
英文摘要
In this study, we examined whether the inhibition of Pim-1 activity, is effective treatment pancreatic cancer, based on the findings that Pim-1 protein expression enhanced under hypoxic conditions. According to the previous reports demonstrating that the protein fused to polypeptides composed of eleven arginine can pass through the cytoplasmic membrane, we constructed an expression vector encoding 11 arginine-signal sequence of Thrombopoietin-dominant negative Pim-1 protein. PCI-43. cells, a pancreatic cancer cell line, were inoculated subcutaneously into the back of SCID mice. Then the mice were treated with the injection of the vectors into the femoral muscle. At 21 days after the treatment, the tumors in the mice treated with the injection of dominant negative PIM-1 expression vector disappeared, whereas the tumors in those treated with empty vector grew. These results suggest that the gene therapy using dominant negative Pim-1 expression vector may be effective for the cancer. However, the doses of expression vector to inject should be reduced for clinical trials. We sought small chemical compound library for the chemical compounds which could suppress the function of Pim-1. We found fourteen small chemical compounds which suppressed the phosphorylation activity of PIM-1 by more than 40 %. We are now planning to examine the in vivo anti-tumor effects of those compounds.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.febslet.2005.02.065
发表时间:
2005-04-11
期刊:
FEBS LETTERS
影响因子:
3.5
作者:
[Kakinuma, Y, Ando, M, Sato, T]
通讯作者:
Sato, T
Cytolytic activity and regulatory functions of inhibitory NK cell receptor-expressing T cells expanded from peripheral blood mononuclear cells.
表达抑制性 NK 细胞受体的 T 细胞从外周血单核细胞扩增而来的溶细胞活性和调节功能。
DOI:
--
发表时间:
2004
期刊:
Blood 104
影响因子:
--
作者:
[Wang, JQ., Kon, J., Mogi, C., Tobo, M., Damirin, A., Sato, K., Komachi, M., Malchinkhuu, E., Murata, N., Kimura, T., Kuwabara, A., Wakamatsu, K., Koizumi, T., Uede, T., Tsujimoto, G., Kurose, H., Sato, T., Harada, A., Misawa, N., Tomura, H., Okajima, F., Takaku H, Takaku H, Matsuda N, Koike T, Kondo K, Tanaka J]
通讯作者:
Tanaka J
Hypoxia suppresses the production of matrix metalloprote-inases and the migration of human monocyte-derived dentritic cells.
缺氧会抑制基质金属蛋白酶的产生和人单核细胞衍生的树突细胞的迁移。
DOI:
--
发表时间:
2005
期刊:
Eur J Immunol 35
影响因子:
--
作者:
[成瀬 達, 石黒 洋, 成瀬 達, 成瀬 達, Okada F, Okada F, Miseki T, Okada F et al., Kakinuma Y, Suzuki A, Zhao W]
通讯作者:
Zhao W
DOI:
10.1002/eji.200526262
发表时间:
2005-12
期刊:
European Journal of Immunology
影响因子:
5.4
作者:
[Wenli Zhao;S. Darmanin;Q. Fu;Jian Chen;Hongyan Cui;Jingxin Wang;F. Okada;J. Hamada;Y. Hattori;T. Kondo;J. Hamuro;M. Asaka;Masanobu Kobayashi]
通讯作者:
Wenli Zhao;S. Darmanin;Q. Fu;Jian Chen;Hongyan Cui;Jingxin Wang;F. Okada;J. Hamada;Y. Hattori;T. Kondo;J. Hamuro;M. Asaka;Masanobu Kobayashi
Prevention of inflammation-mediated acquisition of metastatic properties of benign mouse fibrosarcoma cells by administration of an orally available SOD.
通过口服 SOD 来预防炎症介导的良性小鼠纤维肉瘤细胞的转移特性。
DOI:
--
发表时间:
2006
期刊:
Br J Cancer 94
影响因子:
--
作者:
[成瀬 達, 石黒 洋, 成瀬 達, 成瀬 達, Okada F]
通讯作者:
Okada F
共 15 条
The roles of HDAC and transcription factors in oral cancer development
-
批准号:24592839
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2012
-
负责人:KOBAYASHI Masanobu
-
依托单位:
Establishment of optimal anti-angiogenic therapy against cancer of oral cavity
-
批准号:21592397
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:KOBAYASHI Masanobu
-
依托单位:
Development of therapy for pancreatic cancers which targets adaptation response to hypoxia.
-
批准号:14370170
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.7万
-
财政年份:2002
-
负责人:KOBAYASHI Masanobu
-
依托单位:
Development of gene therapy by using suppressor oncogene vHL for pancreatic cancer
-
批准号:12671132
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2000
-
负责人:KOBAYASHI Masanobu
-
依托单位:
Mechanisms for the formation of granulocytic sarcoma in leukemia
-
批准号:06671068
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$0.64万
-
财政年份:1994
-
负责人:KOBAYASHI Masanobu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
-
批准号:82370751
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:张明
-
依托单位:
靶向纳米颗粒调控HIF-1α通路抑制缺氧三阴性乳腺癌耐药和转移的研究
-
批准号:31900567
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:田浩
-
依托单位:
Egr-1调控低氧下细胞自噬引起肝癌化疗抵抗的机制研究
-
批准号:31100964
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2011
-
负责人:彭琬昕
-
依托单位:
肝刺激因子HSS对肝脏缺血-再灌注损伤的保护作用及机制
-
批准号:81100310
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:李文
-
依托单位:
肝血窦内皮细胞AOC3基因在重症休克-复苏过程中的功能与调控机制
-
批准号:81101419
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:姚骏
-
依托单位:
气体信号分子硫化氢对腰椎间盘髓核细胞凋亡影响的实验研究
-
批准号:81071504
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:李淳德
-
依托单位:
内源性二氧化硫对低氧性肺血管基质重塑的调节作用及机制
-
批准号:81070111
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:杜军保
-
依托单位:
肝癌细胞乏氧微环境下kit配基的表达调控机制及其功能研究
-
批准号:30901448
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:王健
-
依托单位:
PET活体研究心肌乏氧状态与间充质干细胞治疗
-
批准号:30870725
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2008
-
负责人:朱朝晖
-
依托单位:
HIF-1α和SDF-1α/CXCR4在调控神经元前体细胞迁移中的作用研究
-
批准号:30800319
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2008
-
负责人:谭新杰
-
依托单位: